Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
about
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitusPivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKGERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.Is the use of plants in Jordanian folk medicine for the treatment of male sexual dysfunction scientifically based? Review of in vitro and in vivo human and animal studies.Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors.A gas chromatography/mass spectrometry method for the determination of sildenafil, vardenafil and tadalafil and their metabolites in human urine.Metabolism of aildenafil in vivo in rats and in vitro in mouse, rat, dog, and human liver microsomes.Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.Relaxant effects of an alkaloid-rich fraction from Aspidosperma ulei root bark on isolated rabbit corpus cavernosum.
P2860
Q24246544-BA2EEB9F-7E21-48AE-A933-1F877A2FF5A3Q33552229-5E33F5A8-C1D3-40D7-9AB4-C025E172F754Q36735813-765B6515-7C48-4FA2-A1F0-C45FD4B3E024Q37200237-8CEC03AF-3F0B-4C02-AC10-CC53407132B3Q37618221-ED204D2C-2091-4C1A-B802-56C31B0EC709Q38107001-01049468-EB97-4FB9-8838-EE3195C45E7AQ38248275-327A3778-9F96-4F9E-B9C5-EAB62D41191EQ38867698-39563C86-DCB7-43DA-B279-41EF95FA53C6Q40878325-EE543B9A-63D9-4897-A8C5-99B8B279AA48Q43058806-0658ADCE-EF2A-4F57-9E98-1E69538AC07BQ44492595-D6E362D6-E1AC-4489-97B3-C2C0AFCD2B16Q45859354-8E7809F9-8DD3-4DD0-8465-60E78A9DEECDQ46876200-FCD22AC6-A74F-4B52-98B4-55A85EC9DAE8
P2860
Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@ast
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@en
type
label
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@ast
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@en
prefLabel
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@ast
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@en
P2860
P356
P1476
Vardenafil preclinical trial d ...... okinetics, and adverse events.
@en
P2093
Bischoff E
P2860
P2888
P356
10.1038/SJ.IJIR.3901213
P478
16 Suppl 1
P577
2004-06-01T00:00:00Z
P5875
P6179
1012147902